Cerus (CERS) Change in Accured Expenses (2010 - 2026)
Cerus (CERS) reported Change in Accured Expenses of -$7.5 million for Q1 2026, down 210.35% on a YoY basis from $6.8 million in Q1 2025, and down 278.88% sequentially from $4.2 million in Q4 2025.
Cerus (CERS) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Change in Accured Expenses data on file, last reported at -$7.5 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses fell 210.35% year-over-year to -$7.5 million; the trailing twelve-month figure through Mar 2026 stood at -$828000.0 (up 19.92% YoY), and the FY2025 full-year result was $4.3 million, up 294.49% from the prior year.
- Change in Accured Expenses retreated to -$7.5 million in Q1 2026, from $4.2 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $5.9 million in Q4 2022 to a low of -$8.3 million in Q1 2022.
- A 5-year average of -$928529.4 and a median of -$724000.0 in 2023 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses jumped 828.08% in 2022 and sank 498.19% in 2023, its largest moves.
- Tracing CERS's Change in Accured Expenses over 5 years: stood at $5.9 million in 2022, then plunged by 112.25% to -$724000.0 in 2023, then surged by 471.27% to $2.7 million in 2024, then jumped by 56.58% to $4.2 million in 2025, then sank by 278.88% to -$7.5 million in 2026.
- Business Quant data shows CERS's Change in Accured Expenses at -$7.5 million in Q1 2026, $4.2 million in Q4 2025, and -$787000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 145.10 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -250.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn | -7.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.53 Mn |
| Mar 31, 2026 | -7.53 Mn |
| Dec 31, 2025 | 4.21 Mn |
| Dec 31, 2025 | 4.21 Mn |
| Sep 30, 2025 | -787,000.00 |
| Sep 30, 2025 | -787,000.00 |
| Jun 30, 2025 | 3.28 Mn |
| Jun 30, 2025 | 3.28 Mn |
| Mar 31, 2025 | -2.43 Mn |
| Mar 31, 2025 | -2.43 Mn |
| Dec 31, 2024 | 2.69 Mn |
| Dec 31, 2024 | 2.69 Mn |
| Sep 30, 2024 | 235,000.00 |
| Sep 30, 2024 | 235,000.00 |
| Jun 30, 2024 | -1.53 Mn |
| Jun 30, 2024 | -1.53 Mn |
| Mar 31, 2024 | -3.59 Mn |
| Mar 31, 2024 | -3.59 Mn |
| Dec 31, 2023 | -724,000.00 |
| Dec 31, 2023 | -724,000.00 |